Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "Biocon and SRF are buying opportunities. Biocon has been a favourite for me. The dip in the stock is over and I think there is more upside there. Pharma in any case is coming out of a long bear market. So, most pharma stocks are buying opportunities."
"SRF is doing well, the small deep correction there is done with. Larsen & Toubro is a short sell that is surprise because the stock has done nothing. That is also worry for the Nifty also."
"I would advise to sell Pidilite Industries. The charts suggest that the stock is now getting primed up for a deeper correction. If someone is a short term or even a medium term trader, one can always buy it at lower levels should it come down. Market is at elevated level, so Pidilite is a sell," he said.
"Godrej Consumer is a hold. The stock itself is promising higher levels maybe Rs 1,100 -1,150 in the next one year, so I would hold that."
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!